Document
IPR2020-00295, No. 1034-35 Exhibit - US Pat No 4,871,865 (P.T.A.B. Dec. 24, 2019)
Cite Document
IPR2020-00295, No. 1034-35 Exhibit - US Pat No 4,871,865 (P.T.A.B. Dec. 24, 2019)
+ More Snippets
Document
IPR2020-00295, No. 1027-28 Exhibit - Abelson et al, Efficacy of Once Daily Olopatadine 02% Ophthalmic Solution Compared to Twice Daily Olopatadine 01% Ophthalmic Solution for the Treatme...
Cite Document
IPR2020-00295, No. 1027-28 Exhibit - Abelson et al, Efficacy of Once Daily Olopatadine 02% Ophthalmic Solution Compared to Twice Daily Olopatadine 01% Ophthalmic Solution for the Treatment of Ocular I
+ More Snippets
Document
IPR2020-00295, No. 1030-31 Exhibit - Alcon Research, Ltd v Watson Labs, 1 15 cv 01159 D Del Paper 155 March 1, 2018 (P.T.A.B. Dec. 24, 2019)
Cite Document
IPR2020-00295, No. 1030-31 Exhibit - Alcon Research, Ltd v Watson Labs, 1 15 cv 01159 D Del Paper 155 March 1, 2018 (P.T.A.B. Dec. 24, 2019)
+ More Snippets
Document
IPR2020-00295, No. 1018-19 Exhibit - Abelson Gomes, Olopatadine 02% ophthalmic solution the first ophthalmic antiallergy agent with once daily dosing, Expert Opinion on Drug Metabolism To...
Cite Document
IPR2020-00295, No. 1018-19 Exhibit - Abelson Gomes, Olopatadine 02% ophthalmic solution the first ophthalmic antiallergy agent with once daily dosing, Expert Opinion on Drug Metabolism Toxicology, 4
+ More Snippets
Document
IPR2020-00295, No. 1035-36 Exhibit - EP 0235796 (P.T.A.B. Dec. 24, 2019)
Cite Document
IPR2020-00295, No. 1035-36 Exhibit - EP 0235796 (P.T.A.B. Dec. 24, 2019)
+ More Snippets
Document
IPR2020-00295, No. 1043-43 Exhibit - CV of Dr S Craig Dyar (P.T.A.B. Dec. 24, 2019)
Cite Document
IPR2020-00295, No. 1043-43 Exhibit - CV of Dr S Craig Dyar (P.T.A.B. Dec. 24, 2019)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. LBGL1RLAXBLUEX2 (U.S. Pat. App. Dec. 9, 2022)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. LBGL1RLAXBLUEX2 (U.S. Pat. App. Dec. 9, 2022)
+ More Snippets
Docket
14/304,124,
U.S. Patent Application
(June 13, 2014)
Cite Docket
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124 (U.S. Pat. App.)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. L4Y7KLKAGREENX5 (U.S. Pat. App. Jun. 28, 2022)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. L4Y7KLKAGREENX5 (U.S. Pat. App. Jun. 28, 2022)
+ More Snippets
Document
PATADAY ONCE DAILY RELIEF, 206276, Label (Orange Book Oct. 25, 2021)
Cite Document
PATADAY ONCE DAILY RELIEF, 206276, Label (Orange Book Oct. 25, 2021)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. L2J8YC7KGREENX1 (U.S. Pat. App. Apr. 28, 2022)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. L2J8YC7KGREENX1 (U.S. Pat. App. Apr. 28, 2022)
+ More Snippets
Document
IPR2018-01021, No. 1016-17 Exhibit - Apotex v Alcon, paper 2 (P.T.A.B. Jun. 5, 2018)
Cite Document
IPR2018-01021, No. 1016-17 Exhibit - Apotex v Alcon, paper 2 (P.T.A.B. Jun. 5, 2018)
+ More Snippets
Document
IPR2018-01021, No. 1023-24 Exhibit - Apotex v Alcon, paper 8 (P.T.A.B. Jun. 5, 2018)
Cite Document
IPR2018-01021, No. 1023-24 Exhibit - Apotex v Alcon, paper 8 (P.T.A.B. Jun. 5, 2018)
+ More Snippets
Document
IPR2018-01021, No. 1032-33 Exhibit - Orange Book for PAZEO (P.T.A.B. Jun. 5, 2018)
Cite Document
IPR2018-01021, No. 1032-33 Exhibit - Orange Book for PAZEO (P.T.A.B. Jun. 5, 2018)
+ More Snippets
Document
IPR2018-01021, No. 1033-34 Exhibit - European Patent No 0 214 779 (P.T.A.B. Jun. 5, 2018)
Cite Document
IPR2018-01021, No. 1033-34 Exhibit - European Patent No 0 214 779 (P.T.A.B. Jun. 5, 2018)
+ More Snippets